114 related articles for article (PubMed ID: 25178186)
1. Is guideline-adherent adjuvant treatment an equal alternative for patients aged >65 who cannot participate in adjuvant clinical breast cancer trials? A retrospective multi-center cohort study of 4,142 patients.
Van Ewijk R; Wöckel A; Gundelach T; Hancke K; Janni W; Singer S; Kreienberg R; Blettner M; Schwentner L
Arch Gynecol Obstet; 2015 Mar; 291(3):631-40. PubMed ID: 25178186
[TBL] [Abstract][Full Text] [Related]
2. Participation in adjuvant clinical breast cancer trials: does study participation improve survival compared to guideline adherent adjuvant treatment? A retrospective multi-centre cohort study of 9,433 patients.
Schwentner L; Van Ewijk R; Kurzeder C; Hoffmann I; König J; Kreienberg R; Blettner M; Wöckel A
Eur J Cancer; 2013 Feb; 49(3):553-63. PubMed ID: 22959469
[TBL] [Abstract][Full Text] [Related]
3. Triple-negative breast cancer: the impact of guideline-adherent adjuvant treatment on survival--a retrospective multi-centre cohort study.
Schwentner L; Wolters R; Koretz K; Wischnewsky MB; Kreienberg R; Rottscholl R; Wöckel A
Breast Cancer Res Treat; 2012 Apr; 132(3):1073-80. PubMed ID: 22205141
[TBL] [Abstract][Full Text] [Related]
4. The impact of adjuvant radiotherapy on the survival of primary breast cancer patients: a retrospective multicenter cohort study of 8935 subjects.
Wöckel A; Wolters R; Wiegel T; Novopashenny I; Janni W; Kreienberg R; Wischnewsky M; Schwentner L;
Ann Oncol; 2014 Mar; 25(3):628-632. PubMed ID: 24515935
[TBL] [Abstract][Full Text] [Related]
5. Survival of patients with bilateral versus unilateral breast cancer and impact of guideline adherent adjuvant treatment: a multi-centre cohort study of 5292 patients.
Schwentner L; Wolters R; Wischnewsky M; Kreienberg R; Wöckel A
Breast; 2012 Apr; 21(2):171-7. PubMed ID: 21945313
[TBL] [Abstract][Full Text] [Related]
6. Comparing the outcome between multicentric and multifocal breast cancer: what is the impact on survival, and is there a role for guideline-adherent adjuvant therapy? A retrospective multicenter cohort study of 8,935 patients.
Wolters R; Wöckel A; Janni W; Novopashenny I; Ebner F; Kreienberg R; Wischnewsky M; Schwentner L;
Breast Cancer Res Treat; 2013 Dec; 142(3):579-90. PubMed ID: 24258258
[TBL] [Abstract][Full Text] [Related]
7. Guidelines are advantageous, though not essential for improved survival among breast cancer patients.
Wolters R; Wischhusen J; Stüber T; Weiss CR; Krockberger M; Bartmann C; Blettner M; Janni W; Kreienberg R; Schwentner L; Novopashenny I; Wischnewsky M; Wöckel A; Diessner J
Breast Cancer Res Treat; 2015 Jul; 152(2):357-66. PubMed ID: 26105798
[TBL] [Abstract][Full Text] [Related]
8. Highly significant improvement in guideline adherence, relapse-free and overall survival in breast cancer patients when treated at certified breast cancer centres: An evaluation of 8323 patients.
Kreienberg R; Wöckel A; Wischnewsky M
Breast; 2018 Aug; 40():54-59. PubMed ID: 29698925
[TBL] [Abstract][Full Text] [Related]
9. Tumor biology in older breast cancer patients--what is the impact on survival stratified for guideline adherence? A retrospective multi-centre cohort study of 5378 patients.
Ebner F; van Ewijk R; Wöckel A; Hancke K; Schwentner L; Fink V; Kreienberg R; Janni W; Blettner M
Breast; 2015 Jun; 24(3):256-62. PubMed ID: 25769974
[TBL] [Abstract][Full Text] [Related]
10. [Effects of guideline-compliant therapy on the survival of primary breast cancer patients with: results of a retrospective cohort study].
Wolters R; Wöckel A; Wischnewsky M; Kreienberg R
Z Evid Fortbild Qual Gesundhwes; 2011; 105(6):468-75. PubMed ID: 21843852
[TBL] [Abstract][Full Text] [Related]
11. Comorbidity-dependent adherence to guidelines and survival in breast cancer-Is there a role for guideline adherence in comorbid breast cancer patients? A retrospective cohort study with 2137 patients.
Wollschläger D; Meng X; Wöckel A; Janni W; Kreienberg R; Blettner M; Schwentner L
Breast J; 2018 Mar; 24(2):120-127. PubMed ID: 28685896
[TBL] [Abstract][Full Text] [Related]
12. Assessing the impact of CMF-like/Anthracycline-based/Anthracycline-Taxane-based/dose-dense chemotherapy in dependency of positive axillary lymph nodes/hormone receptor-status/grading/T-stage on survival - A retrospective multi-centre cohort study of 3677 patients receiving adjuvant chemotherapy.
Schwentner L; Wöckel A; König J; Janni W; Blettner M; Kreienberg R; Van Ewijk R;
Eur J Cancer; 2014 Nov; 50(17):2905-15. PubMed ID: 25239681
[TBL] [Abstract][Full Text] [Related]
13. Personalized axillary dissection: the number of excised lymph nodes of nodal-positive breast cancer patients has no significant impact on relapse-free and overall survival.
Ebner F; Wöckel A; Janni W; Kreienberg R; Schwentner L; Wischnewsky M
J Cancer Res Clin Oncol; 2017 Sep; 143(9):1823-1831. PubMed ID: 28439713
[TBL] [Abstract][Full Text] [Related]
14. Effects of guideline adherence in primary breast cancer--a 5-year multi-center cohort study of 3976 patients.
Wöckel A; Kurzeder C; Geyer V; Novasphenny I; Wolters R; Wischnewsky M; Kreienberg R; Varga D
Breast; 2010 Apr; 19(2):120-7. PubMed ID: 20117932
[TBL] [Abstract][Full Text] [Related]
15. Aggressive Intrinsic Subtypes in Breast Cancer: A Predictor of Guideline Adherence in Older Patients With Breast Cancer?
Ebner F; Hancke K; Blettner M; Schwentner L; Wöckel A; Kreienberg R; Janni W; van Ewijk R
Clin Breast Cancer; 2015 Aug; 15(4):e189-95. PubMed ID: 25913904
[TBL] [Abstract][Full Text] [Related]
16. Adherence to treatment guidelines and survival in triple-negative breast cancer: a retrospective multi-center cohort study with 9,156 patients.
Schwentner L; Wöckel A; König J; Janni W; Ebner F; Blettner M; Kreienberg R; Van Ewijk R;
BMC Cancer; 2013 Oct; 13():487. PubMed ID: 24138748
[TBL] [Abstract][Full Text] [Related]
17. Exploring patient- and physician-related factors preventing breast cancer patients from guideline-adherent adjuvant chemotherapy-results from the prospective multi-center study BRENDA II.
Schwentner L; Van Ewijk R; Kühn T; Flock F; Felberbaum R; Blettner M; Kreienberg R; Janni W; Wöckel A; Singer S
Support Care Cancer; 2016 Jun; 24(6):2759-66. PubMed ID: 26816089
[TBL] [Abstract][Full Text] [Related]
18. Outcome analysis of primary breast cancer patients who declined adjuvant chemotherapy-results from the prospective multi-center BRENDA II study.
Leinert E; Schwentner L; Janni W; Wöckel A; Herbert SL; Herr D; Kühn T; Flock F; Felberbaum R; Kreienberg R; Fink V; Dayan D; Ernst K; Singer S;
Breast Cancer; 2022 May; 29(3):429-436. PubMed ID: 35178667
[TBL] [Abstract][Full Text] [Related]
19. Adjuvant endocrine therapy in pre- versus postmenopausal patients with steroid hormone receptor-positive breast cancer: results from a large population-based cohort of a cancer registry.
Inwald EC; Koller M; Klinkhammer-Schalke M; Zeman F; Hofstädter F; Lindberg P; Gerstenhauer M; Schüler S; Treeck O; Ortmann O
J Cancer Res Clin Oncol; 2015 Dec; 141(12):2229-40. PubMed ID: 26253629
[TBL] [Abstract][Full Text] [Related]
20. Impact of guideline conformity on breast cancer therapy: results of a 13-year retrospective cohort study.
Wöckel A; Varga D; Atassi Z; Kurzeder C; Wolters R; Wischnewsky M; Wulff C; Kreienberg R
Onkologie; 2010; 33(1-2):21-8. PubMed ID: 20164658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
